Durable complete remission of mycosis fungoides following erythroderma induced by denileukin diftitox.
Kazin
Rebecca
R
Bujanauskas
Paul
P
Vonderheid
Eric C
EC
D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D004167:Diphtheria Toxin / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use*; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000627:therapeutic use
D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox